Advertisement

Cardiovascular Drugs and Therapy

, Volume 29, Issue 4, pp 339–345 | Cite as

Vasotonic Angina as a Cause of Myocardial Ischemia in Women

  • Edina Cenko
  • Raffaele BugiardiniEmail author
ORIGINAL ARTICLE

Abstract

The frequency, presentation, prognosis, and treatment of myocardial ischemia differ in men and women. A large proportion of women who have “normal” coronary arteries on angiography without any significant evidence of flow-limiting disease also have biochemical or imaging evidence of myocardial ischemia. In these women it is believed to be a dysfunction of coronary microcirculation and/or macrocirculation, or vasotonic angina (VA), that leads to abnormal vasoconstriction, and potentially to myocardial infarction, ventricular arrhythmias, and sudden death. Despite having a “normal” or near normal coronary angiography, these women should therefore undergo additional testing with acetylcholine to assess endothelial function. Long-term survival is believed to be relatively good. Predictors of poorer prognosis include documentation of severe endothelial dysfunction and presence of concurrent angiographycally visible coronary atherosclerosis. Because atherosclerosis is common in patients with VA, medical and lifestyle interventions for preventing or treating atherosclerosis should be implemented when appropriate. Angiotensin converting enzyme inhibitors are the mainstays of medical therapy for VA. Other agents have been tried with variable success, including beta-blockers. There are no available data on any specific treatment of VA in women (versus men).

Keywords

Vasotonic angina Cardiac syndrome X Non-obstructive coronary artery disease Women 

Notes

Conflict of Interest

None

References

  1. 1.
    Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734–44.CrossRefPubMedGoogle Scholar
  2. 2.
    Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation. 2015;131:e29–322.CrossRefPubMedGoogle Scholar
  4. 4.
    Hulten E, Pickett C, Bittencourt MS, et al. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. J Am Coll Cardiol. 2013;61:880–92.CrossRefPubMedGoogle Scholar
  5. 5.
    Truong QA, Hayden D, Woodard PK, et al. Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for acute chest pain: the rule-out myocardial infarction with computer-assisted tomography (ROMICAT)-II trial. Circulation. 2013;127:2494–502.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Dolor RJ, Patel MR, Melloni C et al. Noninvasive technologies for the diagnosis of coronary artery disease in women. agency for healthcare research and quality (US); 2012. Report No.: 12-EHC034-EF.Google Scholar
  7. 7.
    Sanders GD, Patel MR, Chatterjee R, et al. Noninvasive technologies for the diagnosis of coronary artery disease in women: future research needs. agency for healthcare research and quality (US); 2013. Report No.: 13-EHC072-EF.Google Scholar
  8. 8.
    Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the national institutes of health-national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). Circulation. 2004;109:2993–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Bugiardini R, Badimon L, Collins P, et al. Angina, “normal” coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med. 2007;4:e12.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Vaccarino V, Badimon L, Corti R, et al. Presentation, management, and outcomes of ischaemic heart disease in women. Nat Rev Cardiol. 2013;10:508–18.CrossRefPubMedGoogle Scholar
  11. 11.
    Bugiardini R. Women, ‘non-specific’ chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome. Eur Heart J. 2006;27:1387–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Johnson BD, Shaw LJ, Pepine CJ, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored women’s ischaemia syndrome evaluation (WISE) study. Eur Heart J. 2006;27:1408–15.CrossRefPubMedGoogle Scholar
  13. 13.
    Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308:883–6.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    von Mering GO, Arant CB, Wessel TR, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). Circulation. 2004;109:722–5.CrossRefGoogle Scholar
  15. 15.
    Sharaf B, Wood T, Shaw L, et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. Am Heart J. 2013;166:134–41.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166:1391–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Hemingway H, McCallum A, Shipley M, Manderbacka K, Martikainen P, Keskimäki I. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA. 2006;295:1404–11.CrossRefPubMedGoogle Scholar
  18. 18.
    Shaw LJ, Merz CN, Pepine CJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the national institutes of health–national heart, lung, and blood institute–sponsored women’s ischemia syndrome evaluation. Circulation. 2006;114:894–904.CrossRefPubMedGoogle Scholar
  19. 19.
    Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54:1561–75.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women’s ischemia syndrome evaluation study and the St James women take heart project. Arch Intern Med. 2009;169:843–50.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation. 2000;102:48–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829–35.CrossRefPubMedGoogle Scholar
  23. 23.
    Arbogast R, Bourassa MG. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease. Am J Cardiol. 1973;32:257–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Kemp Jr HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973;32:375–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Temkin LP, Marcus FI. Nonatherosclerotic myocardial ischemia. J Am Coll Cardiol. 1983;1:1534–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm. Circulation. 1979;59:938–48.CrossRefPubMedGoogle Scholar
  27. 27.
    Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P. Vasotonic angina: a spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation. J Am Coll Cardiol. 1993;22:417–25.CrossRefPubMedGoogle Scholar
  28. 28.
    Cannon 3rd RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43.CrossRefPubMedGoogle Scholar
  29. 29.
    Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 1994;74:531–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009;158:688–94.CrossRefPubMedGoogle Scholar
  31. 31.
    Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: an update. JACC Cardiovasc Imaging. 2011;4:1305–19.CrossRefPubMedGoogle Scholar
  32. 32.
    Khuddus MA, Pepine CJ, Handberg EM, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the national heart, lung and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). J Interv Cardiol. 2010;23:511–9.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004;109:2518–23.CrossRefPubMedGoogle Scholar
  34. 34.
    Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959;27:375–88.CrossRefPubMedGoogle Scholar
  35. 35.
    Bugiardini R, Chierchia S, Davies G, Crea F, Lenzi S, Maseri A. Differential transmyocardial platelet behavior in response to pacing and ergonovine-induced myocardial ischemia. Am Heart J. 1986;112:255–62.CrossRefPubMedGoogle Scholar
  36. 36.
    Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000;35:1850–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Morita H, Ohmori K, Matsuyama T, Mizushige K, Matsuo H. A new noninvasive method of diagnosing vasospastic angina based on dilation response of the left main coronary artery to nitroglycerin as measured by echocardiography. J Am Coll Cardiol. 1996;27:1450–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Maseri A, Severi S, Nes MD, et al. “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978;42:1019–35.CrossRefPubMedGoogle Scholar
  39. 39.
    Kaski JC, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol. 1989;14:1456–63.CrossRefPubMedGoogle Scholar
  40. 40.
    Selzer A, Langston M, Ruggeroli C, Cohn K. Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med. 1976;295:1343–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J. 1996;17:1015–21.CrossRefPubMedGoogle Scholar
  42. 42.
    Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59:655–62.CrossRefPubMedGoogle Scholar
  43. 43.
    Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43–52.CrossRefPubMedGoogle Scholar
  45. 45.
    Xhyheri B, Manfrini O, Mazzolini M, Pizzi C, Bugiardini R. Heart rate variability today. Prog Cardiovasc Dis. 2012;55:321–31.CrossRefPubMedGoogle Scholar
  46. 46.
    Manfrini O, Pizzi C, Viecca M, Bugiardini R. Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling. Atherosclerosis. 2008;197:183–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Bugiardini R, Galvani M, Ferrini D, et al. Myocardial ischemia induced by prostacyclin and iloprost. Clin Pharmacol Ther. 1985;38:101–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Bugiardini R, Galvani M, Ferrini D, et al. Myocardial ischemia during intravenous prostacyclin administration: hemodynamic findings and precautionary measures. Am Heart J. 1987;113:234–40.CrossRefPubMedGoogle Scholar
  49. 49.
    Dagres N, Haude M, Baumgart D, Sack S, Erbel R. Assessment of coronary morphology and flow in a patient with Guillain-Barré syndrome and ST-segment elevation. Clin Cardiol. 2001;24:260–3.CrossRefPubMedGoogle Scholar
  50. 50.
    Manfrini O, Cenko E, Verna E, Salerno Uriarte JA, Bugiardini R. Endothelial dysfunction versus early atherosclerosis: a study with high resolution imaging. Int J Cardiol. 2013;168:1714–6.CrossRefPubMedGoogle Scholar
  51. 51.
    Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–95.PubMedGoogle Scholar
  52. 52.
    Vaccarino V, Badimon L, Corti R, et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European society of cardiology. Cardiovasc Res. 2011;90:9–17.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414–25.PubMedCentralCrossRefPubMedGoogle Scholar
  54. 54.
    Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115–26.CrossRefPubMedGoogle Scholar
  55. 55.
    Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312:1754–63.CrossRefPubMedGoogle Scholar
  56. 56.
    Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34:2949–3003.CrossRefPubMedGoogle Scholar
  57. 57.
    Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol. 1989;63:286–90.CrossRefPubMedGoogle Scholar
  58. 58.
    Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854–6.CrossRefPubMedGoogle Scholar
  59. 59.
    Cannon 3rd RO, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411–7.CrossRefPubMedGoogle Scholar
  60. 60.
    Manfrini O, Bazzocchi G, Luati A, Borghi A, Monari P, Bugiardini R. Coronary spasm reflects inputs from adjacent esophageal system. Am J Physiol Heart Circ Physiol. 2006;290:H2085–91.CrossRefPubMedGoogle Scholar
  61. 61.
    Lerman A, Burnett Jr JC, Higano ST, McKinley LJ, Holmes Jr DR. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme a reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation. 2004;109:53–8.CrossRefPubMedGoogle Scholar
  63. 63.
    Pauly DF, Johnson BD, Anderson RD, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the national heart, lung and blood institute women’s ischemia syndrome evaluation (WISE). Am Heart J. 2011;162:678–84.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Manfrini O, Morrell C, Das R, et al. Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a register-based cohort study on acute coronary syndromes). Am J Cardiol. 2014;113:1628–33.CrossRefPubMedGoogle Scholar
  65. 65.
    Mehta PK, Goykhman P, Thomson LE, et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging. 2011;4:514–22.CrossRefPubMedGoogle Scholar
  66. 66.
    Bugiardini R, Borghi A, Pozzati A, Ottani F, Morgagni GL, Puddu P. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol. 1993;72:343–7.CrossRefPubMedGoogle Scholar
  67. 67.
    Rubinshtein R, Yang EH, Rihal CS, et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J. 2010;31:936–42.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Experimental, Diagnostic and Specialty MedicineUniversity of BolognaBolognaItaly

Personalised recommendations